Edition:
United States

Valeant Pharmaceuticals International Inc (VRX.N)

VRX.N on New York Stock Exchange

15.45USD
2 Dec 2016
Change (% chg)

$0.14 (+0.91%)
Prev Close
$15.31
Open
$15.32
Day's High
$15.75
Day's Low
$15.19
Volume
1,491,535
Avg. Vol
3,537,649
52-wk High
$119.85
52-wk Low
$13.77

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Hold 1.21 December 3 Dec 2016

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 3 3 3 3
(2) OUTPERFORM 1 2 2 2
(3) HOLD 13 12 11 11
(4) UNDERPERFORM 4 4 4 4
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.86 2.81 2.80 2.80

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-16 14 2,340.48 2,504.00 2,277.20 3,511.16
Quarter Ending Mar-17 7 2,245.62 2,364.90 2,135.00 --
Year Ending Dec-16 17 9,602.72 9,765.00 9,525.00 12,725.90
Year Ending Dec-17 18 9,360.86 9,766.00 8,747.70 13,708.20
Earnings (per share)
Quarter Ending Dec-16 17 1.21 1.53 1.04 4.08
Quarter Ending Mar-17 10 1.10 1.35 0.20 --
Year Ending Dec-16 19 5.43 5.76 5.26 14.69
Year Ending Dec-17 19 5.31 6.88 4.26 16.76
LT Growth Rate (%) 2 12.10 12.50 11.70 22.88

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-16 2,494.01 2,479.60 14.41 0.58
Quarter Ending Jun-16 2,459.55 2,420.20 39.35 1.60
Quarter Ending Mar-16 2,380.21 2,369.70 10.51 0.44
Quarter Ending Dec-15 2,751.67 2,788.70 37.03 1.35
Quarter Ending Sep-15 2,779.92 2,786.80 6.88 0.25
Earnings (per share)
Quarter Ending Sep-16 1.75 1.55 0.20 11.42
Quarter Ending Jun-16 1.48 1.40 0.08 5.31
Quarter Ending Mar-16 1.37 1.27 0.10 7.52
Quarter Ending Dec-15 2.61 2.50 0.11 4.03
Quarter Ending Sep-15 2.69 2.74 0.05 1.91

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-16 2,340.48 2,398.27 2,617.84 2,627.35 3,511.16
Quarter Ending Mar-17 2,245.62 2,282.84 2,481.93 2,470.44 --
Year Ending Dec-16 9,602.72 9,679.10 9,931.74 9,944.15 12,725.90
Year Ending Dec-17 9,360.86 9,496.78 10,402.50 10,452.60 13,708.20
Earnings (per share)
Quarter Ending Dec-16 1.21 1.39 2.04 2.06 4.08
Quarter Ending Mar-17 1.10 1.22 1.67 1.67 --
Year Ending Dec-16 5.43 5.63 6.48 6.53 14.69
Year Ending Dec-17 5.31 5.73 7.70 7.71 16.76

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-16 0 2 0 11
Quarter Ending Mar-17 0 1 0 5
Year Ending Dec-16 1 3 0 16
Year Ending Dec-17 0 4 0 17
Earnings
Quarter Ending Dec-16 0 3 0 15
Quarter Ending Mar-17 0 2 0 8
Year Ending Dec-16 0 3 0 17
Year Ending Dec-17 0 3 0 18